TCL Archive Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival March 28, 2014
TCL Archive Broder Appointment Official; Will Keep Retroviral Laboratory, Will Not Serve as NCI Clinical Director January 6, 1989
TCL Archive Also in this 8-page issue: The Cancer Letter wins two awards for its “authoritative examination” of NCI. June 11, 2004